Articles By Anuja Singh

Can Bristol Myers Squibb’s Enterprise-Wide Rollout of Anthropic’s Claude to 30,000 Employees Unlock Billions…

Key Highlights From AI Investment to Business Value Creation Bristol Myers Squibb’s enterprise-wide adoption of Anthropic’s Claude represents…

ByByAnuja Singh Jul 14, 2026
Can Edison Scientific and Population Health Partners’ AI Build the Next $10 Billion Biotech?

Key Highlights The Deal at a Glance Announced on June 29, 2026, the partnership pairs PHP’s proven track…

ByByAnuja Singh Jul 13, 2026
Can a $2.5 Billion AI Alliance Between Insilico Medicine and SK Biopharmaceuticals Rewrite the…

Key Highlights The Deal at a Glance Announced at the BIO 2026 International Convention, the collaboration grants Insilico…

ByByAnuja Singh Jul 13, 2026
Can Sanofi SA’s New AI-Enabled Innovation Hub in China Accelerate Global Drug Development and…

Key Highlights: AI-Integrated Innovation Hubs Redefine Global R&D ModelsSanofi SA’s launch of its innovation and operations centre in…

ByByAnuja Singh Mar 24, 2026
Can Sanofi SA’s $1.2 Billion AI-Driven Autoimmune Alliance with Kali Therapeutics Inc Unlock Next-Gen…

Key Highlights: AI-Powered Biologics Platforms Accelerate Next-Gen Antibody DiscoverySanofi SA’s licensing agreement with Kali Therapeutics Inc highlights the…

ByByAnuja Singh Mar 24, 2026
Can Eli Lilly and Company’s “Triple-G” AI-Enabled Next-Gen Drug Deliver 15%+ Weight Loss and…

Key Highlights: AI-Driven Clinical Design Unlocks Superior Metabolic OutcomesEli Lilly and Company’s late-stage trial results for retatrutide highlight…

ByByAnuja Singh Mar 24, 2026
Image Not Found
Can Bristol Myers Squibb’s Enterprise-Wide Rollout of Anthropic’s Claude to 30,000 Employees Unlock Billions…

Key Highlights From AI Investment to Business Value Creation Bristol Myers Squibb’s enterprise-wide adoption of Anthropic’s Claude represents…

ByByAnuja Singh Jul 14, 2026
Can Edison Scientific and Population Health Partners’ AI Build the Next $10 Billion Biotech?

Key Highlights The Deal at a Glance Announced on June 29, 2026, the partnership pairs PHP’s proven track…

ByByAnuja Singh Jul 13, 2026
Can a $2.5 Billion AI Alliance Between Insilico Medicine and SK Biopharmaceuticals Rewrite the…

Key Highlights The Deal at a Glance Announced at the BIO 2026 International Convention, the collaboration grants Insilico…

ByByAnuja Singh Jul 13, 2026
Can Sanofi SA’s New AI-Enabled Innovation Hub in China Accelerate Global Drug Development and…

Key Highlights: AI-Integrated Innovation Hubs Redefine Global R&D ModelsSanofi SA’s launch of its innovation and operations centre in…

ByByAnuja Singh Mar 24, 2026
Can Sanofi SA’s $1.2 Billion AI-Driven Autoimmune Alliance with Kali Therapeutics Inc Unlock Next-Gen…

Key Highlights: AI-Powered Biologics Platforms Accelerate Next-Gen Antibody DiscoverySanofi SA’s licensing agreement with Kali Therapeutics Inc highlights the…

ByByAnuja Singh Mar 24, 2026
Can Eli Lilly and Company’s “Triple-G” AI-Enabled Next-Gen Drug Deliver 15%+ Weight Loss and…

Key Highlights: AI-Driven Clinical Design Unlocks Superior Metabolic OutcomesEli Lilly and Company’s late-stage trial results for retatrutide highlight…

ByByAnuja Singh Mar 24, 2026
Scroll to Top